ClinConnect ClinConnect Logo
Search / Trial NCT05127642

Hemostatic Assessment of Postpartum Hemorrhage Using Sonoclot Signature

Launched by ASSIUT UNIVERSITY · Nov 8, 2021

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating a new way to quickly assess and manage postpartum hemorrhage, which is heavy bleeding that can occur after childbirth. The study is looking at a device called sonoclot, which helps measure blood clotting and can provide important information about the bleeding. Postpartum hemorrhage is a serious condition that can happen for various reasons, but the most common cause is when the uterus doesn't contract properly after delivery. By using the sonoclot, doctors hope to identify any problems with blood clotting right away, which could lead to better treatment and improved outcomes for mothers.

To be eligible for this trial, participants must be women who are experiencing bleeding within the first 24 hours after giving birth. This includes those with specific conditions that can lead to postpartum hemorrhage, such as uterine atony or certain blood disorders. However, women who bleed after 24 hours, have had a miscarriage, or have experienced bleeding due to trauma will not be included. Those who join the trial can expect to have their blood clotting monitored closely so that any necessary treatments can be given quickly. This study is not yet recruiting participants, but it aims to help improve care for new mothers facing this serious condition.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. patients in childbearing period.
  • 2. Patients with bleeding occurring in the first 24 hours after delivery (primary postpartum hemorrhage).
  • 3. Patients with causes of Postpartum hemorrhage like uterine atony, preeclampsia, blood diseases as inherited and prepartum acquired coagulopathies, and others e.g., acute fatty liver of pregnancy, amniotic fluid embolism, etc.
  • Exclusion Criteria:
  • 1. Patients with bleeding after 24 hours from delivery (secondary postpartum hemorrhage).
  • 2. Patients with miscarriages (bleeding before 22 weeks of gestation) or Antepartum hemorrhage.
  • 3. Traumatic causes of postpartum hemorrhage e.g., rupture uterus, abruptio placenta, Lacerations, hematomas, Uterine inversion, and iatrogenic trauma.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials